Not enough pregnant women are getting recommended screening for infections that can be transmitted to their babies, and many who test positive are not getting the treatment they -- and their infants -- need, according to a study in the American Journal of Obstetrics & Gynecology. The findings, based on two population-based surveys of U.S. labor and delivery records in 2003 and 2004, demonstrate the need for better adherence to clinical guidelines. Pre-delivery screening rates were more than 90% for hepatitis B and rubella, but needed improvement for syphilis (80%), group B streptococcus (72-85%) and chlamydia and gonorrhea (less than 80%). Less than half of women who tested positive for rubella or syphilis received recommended treatment. Read the abstract.
Published in Brief: